Insider Trading History of Cislini Jeff

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Cislini Jeff since 2023. This trader's CIK number is 1969082. At the time of last reporting, Cislini Jeff was the General Counsel of Revolution Medicines, Inc.. (stock ticker symbol RVMD). Also see all insider trading activities at Revolution Medicines, Inc..


Yearly summary of insider trading at Revolution Medicines, Inc. (RVMD) by Cislini Jeff

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 RVMD 0 $0 9,695 $383,908 0 $0
2024 RVMD 0 $0 25,204 $1,157,856 12,000 $438,840
2023 RVMD 0 $0 8,682 $229,727 0 $0


Insider trading of Revolution Medicines, Inc. (RVMD) by Cislini Jeff

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-20 RVMD Sale 1,912 39.61 75,736
2025-06-16 RVMD Sale 1,878 39.83 74,800
2025-03-20 RVMD Sale 2,041 38.71 79,009
2025-03-17 RVMD Sale 1,458 39.04 56,920
2025-01-21 RVMD Sale 2,406 40.50 97,443
2024-12-16 RVMD Sale 1,599 45.40 72,600
2024-11-06 RVMD Option Ex 6,000 36.57 219,420
2024-11-06 RVMD Sale 6,000 60.00 360,000
2024-10-11 RVMD Option Ex 6,000 36.57 219,420
2024-10-11 RVMD Sale 6,000 50.17 301,026
2024-09-16 RVMD Sale 1,454 44.19 64,244
2024-07-09 RVMD Sale 2,399 40.83 97,951
2024-06-26 RVMD Sale 2,000 38.47 76,940
2024-05-21 RVMD Sale 1,500 39.09 58,629
2024-03-27 RVMD Sale 1,500 30.95 46,425
2024-03-18 RVMD Sale 1,252 31.58 39,541
2024-01-22 RVMD Sale 1,500 27.00 40,500
2023-12-18 RVMD Sale 1,229 25.90 31,833
2023-11-20 RVMD Sale 1,500 21.70 32,545
2023-09-28 RVMD Sale 2,000 28.58 57,160
2023-09-18 RVMD Sale 1,214 31.31 38,011
2023-07-31 RVMD Sale 1,500 26.02 39,030
2023-06-20 RVMD Sale 1,239 25.14 31,148

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cislini Jeff (General Counsel of Revolution Medicines, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.